GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
33.76
+4.07 (13.71%)
Apr 23, 2025, 4:00 PM EDT - Market closed
GRAIL Employees
GRAIL had 1,000 employees as of December 31, 2024. The number of employees decreased by 360 or -26.47% compared to the previous year.
Employees
1,000
Change (1Y)
-360
Growth (1Y)
-26.47%
Revenue / Employee
$125,595
Profits / Employee
-$2,027,005
Market Cap
1.14B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000 | -360 | -26.47% |
| Dec 31, 2023 | 1,360 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
GRAL News
- 1 day ago - GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting - PRNewsWire
- 2 days ago - This Cancer Test Could Become Routine—and a Big Seller, Says Analyst - Barrons
- 11 days ago - GRAIL's Galleri Progresses While Back In Accumulation Levels - Seeking Alpha
- 15 days ago - How Does GRAIL Benefit From The Proposed MCED Legislation? - Seeking Alpha
- 2 months ago - GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 2 months ago - GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing - PRNewsWire
- 2 months ago - GRAIL to Present at TD Cowen 45th Annual Health Care Conference - PRNewsWire
- 2 months ago - GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript - Seeking Alpha